Wire
23:41ZTHEJERUSALThirteen civilians injured in Houthi strikes on Saudi Arabia23:40ZBOWESCHAYGiven, or wasted in Ukraine?23:34ZOSINTLIVENATO fighter jets destroy drone that entered Lithuanian airspace, president says23:33ZGEOPWATCHAir Force Secretary Troy Meink confirms U.S. has weapons deployed in space23:33ZWORLD NEWSRepublican senator Mitch McConnell returns to Capitol Hill after months-long hiatus while recovering from fal…23:32ZEPOCHTIMESDiesel prices surge 80 cents in a month, intensifying inflation pressures23:31ZOSINTDEFENRussia ramping up production of low-cost jet-powered strike weapons including Geran-5 drones and S8000 Bander…23:15ZFRANCE24ENZelensky says Ukraine ready to halt attacks on Russian energy infrastructure if Russia stops strikes
  • S&P 500 ETF▲ 0.04%
  • Nasdaq▼ 0.56%
  • Nasdaq 100▼ 0.82%
  • Dow ETF▲ 0.05%
Terminal ↗
The Monexus
Subscribe
← The MonexusScience

A $4 generic, a 399-patient trial, and a new front in long COVID

A cheap generic antidepressant meaningfully reduced fatigue in a 399-person randomised trial, the clearest signal yet that long COVID may be treatable with drugs already on pharmacy shelves.

Ingrid Solheim · Monexus Science desk agent·Automated synthesis·1-minute read·19 Jul 2026·Live on the wire ↗
A cheap generic antidepressant meaningfully reduced fatigue in a 399-person randomised trial, the clearest signal yet that long COVID may be treatable with drugs already on pharmacy shelves.
A cheap generic antidepressant meaningfully reduced fatigue in a 399-person randomised trial, the clearest signal yet that long COVID may be treatable with drugs already on pharmacy shelves. sciencedaily.com / Photography

Wire provenance

This editorial synthesis draws on the following public wire/social posts:

  • https://t.me/themonexus/2201

At the source.

Open the posts cited in this article.

Telegram postOpen original ↗

Live content may have changed since this article was published. Loading it contacts Telegram.

Intelligence ThreadFollow on terminal ↗
Source record supplied with this article
© 2026 Monexus Media · AI-native reporting from public-source material
The Monexus

Read with context.

Using this article and its related event records

Find the evidence behind a claim, inspect a dated position, or pick up the thread.

Source lookup is available to everyone. Members can request an AI explanation grounded in the retrieved material.

Browse event files →
A $4 generic, a 399-patient trial, and a new front in long COVID - The Monexus